Follow this preprint
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocol
View ORCID ProfileShanti Narayanasamy, Fiona Gambanga, Caroline E. Boeke, Krishna Udayakumar, Leo Brothers, Cameron R. Wolfe, Chukwuemeka Agwuocha, Maame Nkansaa Asamoa-Amoakohene, Khamsay Dethleuxay, Bridget C. Griffith, Nervine Hamza, Jessica Joseph, Philip Kimani, Robert Kirungi, Norman Lufesi, Nyuma Mbewe, Elizabeth McCarthy, Mwaba Mulenga, Moses Mukiibi, Tamara Mwenifumbo, Lawrence Ofori-Boadu, Ijeoma Okoli, Sompasong Phongphila, Sean Regan, Edson Rwagasore, Alan Staple, Jessica Tebor, Wesley Tomno, Sabine Umuraza, Hayden B. Bosworth COVID Treatment QuickStart Consortium
doi: https://doi.org/10.1101/2024.10.25.24316111
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Shanti Narayanasamy
1Duke Global Health Institute, Duke University, Durham, North Carolina, USA
2Department of Infectious Diseases and Immunology, Austin Health, Victoria, Australia
Fiona Gambanga
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Caroline E. Boeke
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Krishna Udayakumar
4Duke Global Health Innovation Center, Duke University, Durham, North Carolina, USA
Leo Brothers
5Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA
Cameron R. Wolfe
6Division of Infectious Disease, Duke University, Durham, North Carolina, USA
Chukwuemeka Agwuocha
7Clinton Health Access Initiative, Abuja, Nigeria
Maame Nkansaa Asamoa-Amoakohene
8Clinton Health Access Initiative, Accra, Ghana
Khamsay Dethleuxay
9Department of Healthcare and Rehabilitation at the Ministry of Health, Vientiane, Laos
Bridget C. Griffith
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Nervine Hamza
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Jessica Joseph
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Philip Kimani
10Clinton Health Access Initiative, Nairobi, Kenya
Robert Kirungi
11Clinton Health Access Initiative, Kampala, Uganda
Norman Lufesi
12Malawi Ministry of Health, Lilongwe, Malawi
Nyuma Mbewe
13Zambia Ministry of Health, Lusaka, Zambia
Elizabeth McCarthy
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Mwaba Mulenga
14Clinton Health Access Initiative, Lusaka, Zambia
Moses Mukiibi
15Clinical Pharmacist Quality Assurance, Uganda Ministry of Health, Department of Pharmaceuticals and Natural Medicines, Kampala, Uganda
Tamara Mwenifumbo
16Clinton Health Access Initiative, Lilongwe, Malawi
Lawrence Ofori-Boadu
17Institutional Care Division, Ghana Health Service, Accra, Ghana
Ijeoma Okoli
18Federal Ministry of Health, Abuja, Nigeria
Sompasong Phongphila
19Clinton Health Access Initiative, Vientiane, Laos
Sean Regan
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Edson Rwagasore
20Division Manager for Public Health Surveillance, Emergency Preparedness and Response at Rwanda Biomedical Center (RBC), Kigali, Rwanda
Alan Staple
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Jessica Tebor
3Clinton Health Access Initiative, Boston, Massachusetts, USA
Wesley Tomno
21TB program, Ministry of Health Kenya, Nairobi, Kenya
Sabine Umuraza
22Clinton Health Access Initiative, Kigali, Rwanda
Hayden B. Bosworth
23Department of Population Health Sciences, Duke University, Durham, North Carolina, USA

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 27, 2024.
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocol
Shanti Narayanasamy, Fiona Gambanga, Caroline E. Boeke, Krishna Udayakumar, Leo Brothers, Cameron R. Wolfe, Chukwuemeka Agwuocha, Maame Nkansaa Asamoa-Amoakohene, Khamsay Dethleuxay, Bridget C. Griffith, Nervine Hamza, Jessica Joseph, Philip Kimani, Robert Kirungi, Norman Lufesi, Nyuma Mbewe, Elizabeth McCarthy, Mwaba Mulenga, Moses Mukiibi, Tamara Mwenifumbo, Lawrence Ofori-Boadu, Ijeoma Okoli, Sompasong Phongphila, Sean Regan, Edson Rwagasore, Alan Staple, Jessica Tebor, Wesley Tomno, Sabine Umuraza, Hayden B. Bosworth
medRxiv 2024.10.25.24316111; doi: https://doi.org/10.1101/2024.10.25.24316111
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3175)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13147)
- Forensic Medicine (17)
- Gastroenterology (878)
- Genetic and Genomic Medicine (4980)
- Geriatric Medicine (458)
- Health Economics (762)
- Health Informatics (3134)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (462)
- Medical Ethics (121)
- Nephrology (511)
- Neurology (4727)
- Nursing (252)
- Nutrition (700)
- Oncology (2435)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (315)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1263)
- Primary Care Research (536)
- Public and Global Health (7296)
- Radiology and Imaging (1635)
- Respiratory Medicine (953)
- Rheumatology (468)
- Sports Medicine (409)
- Surgery (527)
- Toxicology (66)
- Transplantation (226)
- Urology (196)